Literature DB >> 2511768

Effects of prolonged hyperinsulinemia on erythropoiesis in fetal sheep.

B S Stonestreet1, M Goldstein, W Oh, J A Widness.   

Abstract

Offspring of diabetic mothers have an increased incidence of neonatal polycythemia, decreased oxygen tension in cord blood at delivery, and elevated plasma erythropoietin levels at birth. Experimental fetal hyperinsulinemia has been associated with reduced fetal oxygen content and increased erythropoietin concentration. To test the hypothesis that prolonged fetal hyperinsulinemia results in increased fetal erythropoiesis and red cell volume during gestation, we infused insulin or placebo for 11 +/- 0.2 (+/- SE) days into chronically catheterized fetal sheep, beginning at 124 days of gestation. Indices of fetal erythropoiesis, red cell and blood volume were measured before and during the infusions. Insulin infusion resulted in increased plasma insulin, decreased plasma glucose, and decreased oxygen saturation values. The nucleated red blood cell (RBC) and RBC counts were significantly higher in the insulin- compared with the placebo-treated fetal sheep after 6-8 and 9-12 days of infusion, respectively. Although erythropoietin concentration did not differ between the groups, red cell volume expressed as a change from the base-line value was significantly higher in the insulin-treated group. We conclude that prolonged fetal hyperinsulinemia augmented erythropoiesis and red cell volume during late gestation in fetal sheep.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2511768     DOI: 10.1152/ajpregu.1989.257.5.R1199

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Hematologic profile of the fetus with systemic inflammatory response syndrome.

Authors:  Roberto Romero; Zeynep Alpay Savasan; Tinnakorn Chaiworapongsa; Stanley M Berry; Juan Pedro Kusanovic; Sonia S Hassan; Bo Hyun Yoon; Samuel Edwin; Moshe Mazor
Journal:  J Perinat Med       Date:  2011-09-30       Impact factor: 1.901

2.  Neutralizing anti-interleukin-1β antibodies reduce ischemia-related interleukin-1β transport across the blood-brain barrier in fetal sheep.

Authors:  Aparna Patra; Xiaodi Chen; Grazyna B Sadowska; Jiyong Zhang; Yow-Pin Lim; James F Padbury; William A Banks; Barbara S Stonestreet
Journal:  Neuroscience       Date:  2017-01-09       Impact factor: 3.590

3.  Anti-IL-6 neutralizing antibody modulates blood-brain barrier function in the ovine fetus.

Authors:  Jiyong Zhang; Grazyna B Sadowska; Xiaodi Chen; Seon Yeong Park; Jeong-Eun Kim; Courtney A Bodge; Erin Cummings; Yow-Pin Lim; Oleksandr Makeyev; Walter G Besio; John Gaitanis; William A Banks; Barbara S Stonestreet
Journal:  FASEB J       Date:  2015-01-21       Impact factor: 5.191

4.  Direct relationship of antepartum glucose control and fetal erythropoietin in human type 1 (insulin-dependent) diabetic pregnancy.

Authors:  J A Widness; K A Teramo; G K Clemons; P Voutilainen; U H Stenman; S M McKinlay; R Schwartz
Journal:  Diabetologia       Date:  1990-06       Impact factor: 10.122

Review 5.  Fetoplacental oxygen homeostasis in pregnancies with maternal diabetes mellitus and obesity.

Authors:  Gernot Desoye; Anthony M Carter
Journal:  Nat Rev Endocrinol       Date:  2022-07-28       Impact factor: 47.564

6.  Ischemia-reperfusion impairs blood-brain barrier function and alters tight junction protein expression in the ovine fetus.

Authors:  X Chen; S W Threlkeld; E E Cummings; I Juan; O Makeyev; W G Besio; J Gaitanis; W A Banks; G B Sadowska; B S Stonestreet
Journal:  Neuroscience       Date:  2012-09-15       Impact factor: 3.590

7.  A routine biomarker-based risk prediction model for metabolic syndrome in urban Han Chinese population.

Authors:  Wenchao Zhang; Qicai Chen; Zhongshang Yuan; Jing Liu; Zhaohui Du; Fang Tang; Hongying Jia; Fuzhong Xue; Chengqi Zhang
Journal:  BMC Public Health       Date:  2015-01-31       Impact factor: 3.295

8.  Association between erythrocyte parameters and metabolic syndrome in urban Han Chinese: a longitudinal cohort study.

Authors:  Shuo Wu; Haiyan Lin; Chengqi Zhang; Qian Zhang; Dongzhi Zhang; Yongyuan Zhang; Wenjia Meng; Zhenxin Zhu; Fang Tang; Fuzhong Xue; Yanxun Liu
Journal:  BMC Public Health       Date:  2013-10-21       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.